Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Propert

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Cancer Research|September 15, 1996
Expression of cell cycle-regulated proteins in prostate cancerR D Mashal, S Lester, C Corless, et al.
Medical and Pediatric Oncology|January 1, 1990
Phase II trial of etoposide and cis-diaminodichloro-platinum in patients with refractory and relapsed Hodgkin's disease: Cancer and Leukemia Group B (CALGB) Study 8353M E Rybak, K McCarroll, R J Kaplan, et al.
Medical and Pediatric Oncology|January 1, 1990
Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: a Cancer and Leukemia Group B StudyS L Graziano, K Lee, K J Propert, et al.
Clinical Genetics|September 20, 2012
Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and familiesM Reiff, K Ross, S Mulchandani, et al.
The Journal of Urology|February 7, 2001
A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study GroupK J Propert, A J Schaeffer, C M Brensinger, et al.
International Journal of Radiation Oncology, Biology, Physics|June 2, 1998
Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancerC J Beard, C Lamb, L Buswell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a Cancer and Leukemia Group B studyJ B Hargis, J R Anderson, K J Propert, et al.
The American Journal of Clinical Nutrition|August 2, 2000
Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosisN Stettler, D A Kawchak, L L Boyle, et al.
American Journal of Clinical Oncology|April 16, 1998
5-Fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: an Eastern Cooperative Oncology Group phase II study (E1889)J D Berlin, K J Propert, D Trump, et al.
Cancer|September 1, 1993
Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancerH Kreisman, A Lisbona, L Olson, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Cancer Research|September 15, 1996
Expression of cell cycle-regulated proteins in prostate cancerR D Mashal, S Lester, C Corless, et al.
Medical and Pediatric Oncology|January 1, 1990
Phase II trial of etoposide and cis-diaminodichloro-platinum in patients with refractory and relapsed Hodgkin's disease: Cancer and Leukemia Group B (CALGB) Study 8353M E Rybak, K McCarroll, R J Kaplan, et al.
Medical and Pediatric Oncology|January 1, 1990
Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: a Cancer and Leukemia Group B StudyS L Graziano, K Lee, K J Propert, et al.
Clinical Genetics|September 20, 2012
Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and familiesM Reiff, K Ross, S Mulchandani, et al.
The Journal of Urology|February 7, 2001
A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study GroupK J Propert, A J Schaeffer, C M Brensinger, et al.
International Journal of Radiation Oncology, Biology, Physics|June 2, 1998
Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancerC J Beard, C Lamb, L Buswell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a Cancer and Leukemia Group B studyJ B Hargis, J R Anderson, K J Propert, et al.
The American Journal of Clinical Nutrition|August 2, 2000
Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosisN Stettler, D A Kawchak, L L Boyle, et al.
American Journal of Clinical Oncology|April 16, 1998
5-Fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: an Eastern Cooperative Oncology Group phase II study (E1889)J D Berlin, K J Propert, D Trump, et al.
Cancer|September 1, 1993
Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancerH Kreisman, A Lisbona, L Olson, et al.
Pageof 6